Further analysis demonstrated that this is a consequence of Eμ-Myc/cRel−/− lymphomas having lost expression of CHK1 protein itself, an effect that also results in resistance to CCT244747 treatment in vivo. The gene discussed is CHEK1; the disease is lymphoma.